| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Short Communications |
From the Departments of Clinical Oncology*
at the
Sir Y. K. Pao Centre for Cancer, Surgery,
and Anatomical and Cellular Pathology,
The
Chinese University of Hong Kong, Hong Kong, China
Hepatocellular carcinoma (HCC) is a common and highly malignant tumor that is prevalent in Southeast Asia. Although the etiological factors associated are now well recognized, the interactions between individual factors and the molecular mechanisms by which they lead to cancer remain unclear. Cytogenetic analysis on HCC has been limited because of poor hepatocyte growth in vitro. The recently developed technique of comparative genomic hybridization (CGH), however, permits screening of the entire genome without the need of cell culture. CGH was applied to the study of genomic aberrations in 67 surgically resected samples of HCC, 3 of adenomatous hyperplasia (AH), and 12 of nontumorous cirrhotic liver surrounding the tumors. All samples were from patients of a racially and etiologically homogeneous population in Southern China, where chronic hepatitis B virus infection is the main etiological factor. CGH analysis of the HCC samples revealed frequent copy number gain of 1q (48/67 cases, 72%), 8q (32/67 cases, 48%), 17q (20/67 cases, 30%), and 20q (25/67 cases, 37%) and common losses on 4q (29/67 cases, 43%), 8p (25/67 cases, 37%), 13q (25/67 cases, 37%), and 16q (20/67 cases, 30%). Our finding of a high incidence of 1q gain strongly suggested this aberration was associated with the development of HCC. Genomic abnormalities were detected in 1 of the 3 AH specimens but absent in all 12 cirrhotic tissues surrounding the tumor. Clinical staging classified 3/67 HCC cases as T1, 53 cases as T2, and 11 cases as T3. No significant difference in the pattern of genomic imbalances was detected between stages T2 and T3. A significant copy number loss of 4q11-q23 was, however, identified in those tumors larger than 3 cm in diameter. Of particular interest was the identification of 8q copy number gain in all 12 cases of HCC that arose in a noncirrhotic liver, compared with only 20/55 cases in HCC arising in a cirrhotic liver. We suggest that 8q over-representation is likely associated with a growth advantage and proliferative stimulation that have encouraged malignant changes in the noncirrhotic human liver.
This article has been cited by other articles:
![]() |
L. Zhang, Z. Smit-McBride, X. Pan, J. Rheinhardt, and J. W. B. Hershey An Oncogenic Role for the Phosphorylated h-Subunit of Human Translation Initiation Factor eIF3 J. Biol. Chem., August 29, 2008; 283(35): 24047 - 24060. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. V. Iakovlev, N. C.R. Arneson, V. Wong, C. Wang, S. Leung, G. Iakovleva, K. Warren, M. Pintilie, and S. J. Done Genomic Differences Between Pure Ductal Carcinoma In Situ of the Breast and that Associated with Invasive Disease: a Calibrated aCGH Study Clin. Cancer Res., July 15, 2008; 14(14): 4446 - 4454. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Liu, L. Du, M. Osato, E. H. Teo, F. Qian, H. Jin, F. Zhen, J. Xu, L. Guo, H. Huang, et al. The zebrafish udu gene encodes a novel nuclear factor and is essential for primitive erythroid cell development Blood, July 1, 2007; 110(1): 99 - 106. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. Patil, I. Gutgemann, J. Zhang, C. Ho, S.-T. Cheung, D. Ginzinger, R. Li, K. J. Dykema, S. So, S.-T. Fan, et al. Array-based comparative genomic hybridization reveals recurrent chromosomal aberrations and Jab1 as a potential target for 8q gain in hepatocellular carcinoma Carcinogenesis, December 1, 2005; 26(12): 2050 - 2057. [Abstract] [Full Text] [PDF] |
||||
![]() |
R.-H. Yuan, Y.-M. Jeng, H.-L. Chen, F.-J. Hsieh, C.-Y. Yang, P.-H. Lee, and H.-C. Hsu Opposite Roles of Human Pancreatitis-Associated Protein and REG1A Expression in Hepatocellular Carcinoma: Association of Pancreatitis-Associated Protein Expression with Low-Stage Hepatocellular Carcinoma, {beta}-Catenin Mutation, and Favorable Prognosis Clin. Cancer Res., April 1, 2005; 11(7): 2568 - 2575. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Midorikawa, S. Tsutsumi, K. Nishimura, N. Kamimura, M. Kano, H. Sakamoto, M. Makuuchi, and H. Aburatani Distinct Chromosomal Bias of Gene Expression Signatures in the Progression of Hepatocellular Carcinoma Cancer Res., October 15, 2004; 64(20): 7263 - 7270. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Bilger, L. M. Bennett, R. A. Carabeo, T. A. Chiaverotti, C. Dvorak, K. M. Liss, S. A. Schadewald, H. C. Pitot, and N. R. Drinkwater A Potent Modifier of Liver Cancer Risk on Distal Mouse Chromosome 1: Linkage Analysis and Characterization of Congenic Lines Genetics, June 1, 2004; 167(2): 859 - 866. [Abstract] [Full Text] [PDF] |
||||
![]() |
L.-H. Li, J.-C. Li, Y.-F. Lin, C.-Y. Lin, C.-Y. Chen, and S.-F. Tsai Genomic shotgun array: a procedure linking large-scale DNA sequencing with regional transcript mapping Nucleic Acids Res., February 11, 2004; 32(3): e27 - e27. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Wilkens, P. Flemming, M. Gebel, J. Bleck, C. Terkamp, L. Wingen, H. Kreipe, and B. Schlegelberger Induction of aneuploidy by increasing chromosomal instability during dedifferentiation of hepatocellular carcinoma PNAS, February 3, 2004; 101(5): 1309 - 1314. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Chen, S. T. Cheung, S. So, S. T. Fan, C. Barry, J. Higgins, K.-M. Lai, J. Ji, S. Dudoit, I. O.L. Ng, et al. Gene Expression Patterns in Human Liver Cancers Mol. Biol. Cell, June 1, 2002; 13(6): 1929 - 1939. [Abstract] [Full Text] [PDF] |
||||
![]() |
S.-H. Liu, C.-Y. Lin, S.-Y. Peng, Y.-M. Jeng, H.-W. Pan, P.-L. Lai, C.-L. Liu, and H.-C. Hsu Down-Regulation of Annexin A10 in Hepatocellular Carcinoma Is Associated with Vascular Invasion, Early Recurrence, and Poor Prognosis in Synergy with p53 Mutation Am. J. Pathol., May 1, 2002; 160(5): 1831 - 1837. [Abstract] [Full Text] [PDF] |
||||
![]() |
A Marchio, B Terris, M Meddeb, P Pineau, A Duverger, P Tiollais, A Bernheim, and A Dejean Chromosomal abnormalities in liver cell dysplasia detected by comparative genomic hybridisation Mol. Pathol., August 1, 2001; 54(4): 270 - 274. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Wong, W.-C. Lam, P. B.-S. Lai, E. Pang, W.-Y. Lau, and P. J. Johnson Hypomethylation of Chromosome 1 Heterochromatin DNA Correlates with q-Arm Copy Gain in Human Hepatocellular Carcinoma Am. J. Pathol., August 1, 2001; 159(2): 465 - 471. [Abstract] [Full Text] |
||||
![]() |
L. Wilkens, M. Bredt, P. Flemming, Y. Schwarze, T. Becker, M. Mengel, R. von Wasielewski, J. Klempnauer, and H. Kreipe Diagnostic Impact of Fluorescence in Situ Hybridization in the Differentiation of Hepatocellular Adenoma and Well-Differentiated Hepatocellular Carcinoma J. Mol. Diagn., May 1, 2001; 3(2): 68 - 73. [Abstract] [Full Text] |
||||
![]() |
Y. Yamamoto, M. Sakamoto, G. Fujii, K. Kanetaka, M. Asaka, and S. Hirohashi Cloning and Characterization of a Novel Gene, DRH1, Down-Regulated in Advanced Human Hepatocellular Carcinoma Clin. Cancer Res., February 1, 2001; 7(2): 297 - 303. [Abstract] [Full Text] |
||||
![]() |
G.-J. Wu, C. S. Sinclair, J. Paape, J. N. Ingle, P. C. Roche, C. D. James, and F. J. Couch 17q23 Amplifications in Breast Cancer Involve the PAT1, RAD51C, PS6K, and SIGMA1B Genes Cancer Res., October 1, 2000; 60(19): 5371 - 5375. [Abstract] [Full Text] |
||||
![]() |
N. Wong, P. Lai, E. Pang, L.-F. Fung, Z. Sheng, V. Wong, W. Wang, Y. Hayashi, E. Perlman, S. Yuna, et al. Genomic Aberrations in Human Hepatocellular Carcinomas of Differing Etiologies Clin. Cancer Res., October 1, 2000; 6(10): 4000 - 4009. [Abstract] [Full Text] |
||||
![]() |
R. G. Weber, T. Pietsch, D. von Schweinitz, and P. Lichter Characterization of Genomic Alterations in Hepatoblastomas : A Role for Gains on Chromosomes 8q and 20 as Predictors of Poor Outcome Am. J. Pathol., August 1, 2000; 157(2): 571 - 578. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Gilbert, L. Galarneau, A. Lamontagne, S. Roy, and L. Bélanger The Hepatitis B Virus Core Promoter Is Strongly Activated by the Liver Nuclear Receptor Fetoprotein Transcription Factor or by Ectopically Expressed Steroidogenic Factor 1 J. Virol., June 1, 2000; 74(11): 5032 - 5039. [Abstract] [Full Text] |
||||
![]() |
G. D. Kirk, A.-M. Camus-Randon, M. Mendy, J. J. Goedert, P. Merle, C. Trepo, C. Brechot, P. Hainaut, and R. Montesano Ser-249 p53 Mutations in Plasma DNA of Patients With Hepatocellular Carcinoma From The Gambia J Natl Cancer Inst, January 19, 2000; 92(2): 148 - 153. [Abstract] [Full Text] [PDF] |
||||
![]() |
L.-X. Qin, Z.-Y. Tang, J. S. T. Sham, Z.-C. Ma, S.-L. Ye, X.-D. Zhou, Z.-Q. Wu, J. M. Trent, and X.-Y. Guan The Association of Chromosome 8p Deletion and Tumor Metastasis in Human Hepatocellular Carcinoma Cancer Res., November 1, 1999; 59(22): 5662 - 5665. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |